Junko Kami1, Kimimasa Muranaka1, Yasuo Yanagi1, Ryo Obata2, Yasuhiro Tamaki1, Masabumi Shibuya3. 1. Department of Ophthalmology, Faculty of Medicine, University of Tokyo, Tokyo, Japan. 2. Department of Ophthalmology, Faculty of Medicine, University of Tokyo, Tokyo, Japan. robata-tky@umin.ac.jp. 3. Department of Genetics, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Abstract
PURPOSE: To investigate the role played by receptors of vascular endothelial growth factors, Flt-1 and KDR/Flk-1, on an experimental model of choroidal neovascularization (CNV). METHODS: The vascular endothelial growth factor-A (VEGF-A) receptor-specific tyrosine kinase inhibitor SU5416 was administered to a laser-induced mouse model of CNV. The formation of CNV and the degree of vascular permeability in Flt-1 tyrosine kinase domain-deficient mice were also investigated. RESULTS: SU5416 reduced vascularity and vascular endothelial cell proliferation, and promoted endothelial cell apoptosis within CNV. Furthermore, the formation of CNV and the degree of vascular permeability were significantly reduced in Flt-1 tyrosine kinase domain-deficient mice, and this effect was enhanced by the administration of SU5416. CONCLUSIONS: Both Flt-1 and KDR/Flk-1 have a significant role in CNV formation. Suppression of apoptosis may be involved in the process.
PURPOSE: To investigate the role played by receptors of vascular endothelial growth factors, Flt-1 and KDR/Flk-1, on an experimental model of choroidal neovascularization (CNV). METHODS: The vascular endothelial growth factor-A (VEGF-A) receptor-specific tyrosine kinase inhibitor SU5416 was administered to a laser-induced mouse model of CNV. The formation of CNV and the degree of vascular permeability in Flt-1 tyrosine kinase domain-deficient mice were also investigated. RESULTS:SU5416 reduced vascularity and vascular endothelial cell proliferation, and promoted endothelial cell apoptosis within CNV. Furthermore, the formation of CNV and the degree of vascular permeability were significantly reduced in Flt-1 tyrosine kinase domain-deficient mice, and this effect was enhanced by the administration of SU5416. CONCLUSIONS: Both Flt-1 and KDR/Flk-1 have a significant role in CNV formation. Suppression of apoptosis may be involved in the process.
Authors: P Carmeliet; L Moons; A Luttun; V Vincenti; V Compernolle; M De Mol; Y Wu; F Bono; L Devy; H Beck; D Scholz; T Acker; T DiPalma; M Dewerchin; A Noel; I Stalmans; A Barra; S Blacher; T VandenDriessche; A Ponten; U Eriksson; K H Plate; J M Foidart; W Schaper; D S Charnock-Jones; D J Hicklin; J M Herbert; D Collen; M G Persico Journal: Nat Med Date: 2001-05 Impact factor: 53.440
Authors: M S Seo; N Kwak; H Ozaki; H Yamada; N Okamoto; E Yamada; D Fabbro; F Hofmann; J M Wood; P A Campochiaro Journal: Am J Pathol Date: 1999-06 Impact factor: 4.307
Authors: L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park Journal: N Engl J Med Date: 1994-12-01 Impact factor: 91.245
Authors: M Kernt; S Thiele; C Hirneiss; A S Neubauer; C A Lackerbauer; A Wolf; K H Eibl; C Haritoglou; M W Ulbig; A Kampik Journal: Ophthalmologe Date: 2011-05 Impact factor: 1.059
Authors: Seungwoon Seo; Hardeep P Singh; Pedro M Lacal; Amy Sasman; Anees Fatima; Ting Liu; Kathryn M Schultz; Douglas W Losordo; Ordan J Lehmann; Tsutomu Kume Journal: Proc Natl Acad Sci U S A Date: 2011-12-14 Impact factor: 11.205